Companies: 10,795·Total market cap: $144.5T
Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.

AMRXNASDAQHealthcare● Active
$13.75
+$0.23(+1.70%)
Market Cap$4.4B
P/E Ratio
52W High$15.42
52W Low$7.07
Overview

Amneal Pharmaceuticals, Inc. (AMRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AMRX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.38amrx eps ttm · amrx earnings per shareEarnings history
PE Ratio (TTM)36.3×amrx pe ratio ttm · amrx price to earningsPE Ratio deep dive
Revenue (TTM)$3.0Bamrx revenue ttm · amrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes amrx pay dividends · amrx dividend yieldDividend history
Shares Outstanding313.4Mamrx shares outstanding · amrx floatShares outstanding history
Next EarningsAug 4, 2026Est.amrx earnings date · amrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$3.02B▲ +8.05% YoY
202320242025
amneal pharmaceuticals, inc. revenue · amrx revenue 2025
FY 2025Net Income$72.1M▲ +161.65% YoY
202320242025
amneal pharmaceuticals, inc. net income · amrx profit 2025
FY 2025EPS$0.23▲ +160.53% YoY
202320242025
amrx eps · amneal pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $3.05BNet Income: $122.4MEPS: $0.38View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy16 analystsis amrx a buy · amrx analyst rating
Strong Buy
0
Buy
10
Hold
6
Sell
0
Strong Sell
0
12-Month Price Target
$16.00Low
$13.75Current
$17.33Avg Target26.04% upside
$19.00High
amrx price target · amrx 12 month forecast

Total: 16 · Buy rate: 62.5%

The AMRX analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $17.33, representing +26.04% upside from the current price of $13.75.

Stock Performance

Full History
1D+1.70%
1W+9.39%
1M+4.17%
3M+3.85%
YTD+9.13%
1Y+80.68%
5Y+140.81%

About Amneal Pharmaceuticals, Inc.

CEOChirag K. Patel
IPO DateMay 7, 2018
Employees8,300
CountryUS
Websiteamneal.com

Amneal Pharmaceuticals, Inc. together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and ther…

what is amneal pharmaceuticals, inc. · amrx stock overview · amneal pharmaceuticals, inc. company profile · who is amneal pharmaceuticals, inc. ceo · amrx NASDAQ · amneal pharmaceuticals, inc. headquarters · amneal pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Amneal Pharmaceuticals, Inc. (AMRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 7, 2018. As of the latest trading session, AMRX stock price is $13.75, with a market capitalization of $4.4B. The stock has returned +80.68% over the past 12 months and +9.13% year-to-date.

According to 16 Wall Street analysts, the consensus rating for Amneal Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $17.33. In fiscal year 2025, Amneal Pharmaceuticals, Inc. reported revenue of $3.0B and net income of $72.1M. For detailed data — including Amneal Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Amneal Pharmaceuticals, Inc. (AMRX) stock price is $13.75. The stock is traded on NASDAQ under the ticker symbol AMRX. The 52-week range is $7.07 – $15.42.

AMRX stock priceAMRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice